Literature DB >> 12182275

Change in emotion-regulation strategy for women with metastatic breast cancer following supportive-expressive group therapy.

Janine Giese-Davis1, Cheryl Koopman, Lisa D Butler, Catherine Classen, Matthew Cordova, Pat Fobair, Jane Benson, Helena C Kraemer, David Spiegel.   

Abstract

Four relatively independent emotion-regulation constructs (suppression of negative affect, restraint, repression, and emotional self-efficacy) were tested as outcomes in a randomized trial of supportive-expressive group therapy for women with metastatic breast cancer. Results indicate that report of suppression of negative affect decreased and restraint of aggressive, inconsiderate, impulsive, and irresponsible behavior increased in the treatment group as compared with controls over 1 year in the group. Groups did not differ over time on repression or emotional self-efficacy. This study provides evidence that emotion-focused therapy can help women with advanced breast cancer to become more expressive without becoming more hostile. Even though these aspects of emotion-regulation appear trait-like within the control group, significant change was observed with treatment.

Entities:  

Mesh:

Year:  2002        PMID: 12182275     DOI: 10.1037//0022-006x.70.4.916

Source DB:  PubMed          Journal:  J Consult Clin Psychol        ISSN: 0022-006X


  33 in total

1.  Self-report and linguistic indicators of emotional expression in narratives as predictors of adjustment to cancer.

Authors:  Jason E Owen; Janine Giese-Davis; Matt Cordova; Carol Kronenwetter; Mitch Golant; David Spiegel
Journal:  J Behav Med       Date:  2006-07-15

2.  Psychological adjustment following diagnosis and treatment of cancer: an examination of the moderating role of positive and negative emotional expressivity.

Authors:  Phillip J Quartana; Kimberly K Laubmeier; Sandra G Zakowski
Journal:  J Behav Med       Date:  2006-08-08

3.  Emotions and social relationships for breast and gynecologic patients: a qualitative study of coping with recurrence.

Authors:  Lisa M Thornton; Anna O Levin; Caroline S Dorfman; Neha Godiwala; Carolyn Heitzmann; Barbara L Andersen
Journal:  Psychooncology       Date:  2013-10-14       Impact factor: 3.894

4.  Emotion suppression and mortality risk over a 12-year follow-up.

Authors:  Benjamin P Chapman; Kevin Fiscella; Ichiro Kawachi; Paul Duberstein; Peter Muennig
Journal:  J Psychosom Res       Date:  2013-08-06       Impact factor: 3.006

5.  Exercise, supportive group therapy, and mood profile of Greek cancer patients: intervention effect and related comparisons.

Authors:  D Papastergiou; D Kokaridas; K Bonotis; N Diggelidis; A Patsiaouras
Journal:  Support Care Cancer       Date:  2018-05-03       Impact factor: 3.603

6.  Deconstructing therapeutic mechanisms in cancer support groups: do we express more emotion when we tell stories or talk directly to each other?

Authors:  Rie Tamagawa; Yong Li; Theo Gravity; Karen Altree Piemme; Sue DiMiceli; Kate Collie; Janine Giese-Davis
Journal:  J Behav Med       Date:  2014-08-06

7.  Living with metastatic breast cancer: a qualitative analysis of physical, psychological, and social sequelae.

Authors:  Catherine E Mosher; Courtney Johnson; Maura Dickler; Larry Norton; Mary Jane Massie; Katherine DuHamel
Journal:  Breast J       Date:  2013-03-26       Impact factor: 2.431

8.  How language affects peer responsiveness in an online cancer support group: implications for treatment design and facilitation.

Authors:  Andrea C Lewallen; Jason E Owen; Erin O'Carroll Bantum; Annette L Stanton
Journal:  Psychooncology       Date:  2014-02-11       Impact factor: 3.894

9.  Exploring Emotion-Regulation and Autonomic Physiology in Metastatic Breast Cancer Patients: Repression, Suppression, and Restraint of Hostility.

Authors:  Janine Giese-Davis; Ansgar Conrad; Bita Nouriani; David Spiegel
Journal:  Pers Individ Dif       Date:  2008-01

Review 10.  Psychosocial interventions for patients with advanced cancer - a systematic review of the literature.

Authors:  R J Uitterhoeve; M Vernooy; M Litjens; K Potting; J Bensing; P De Mulder; T van Achterberg
Journal:  Br J Cancer       Date:  2004-09-13       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.